source
- Novartis-partnered Matchpoint Therapeutics raises $150 million Series B to fund clinical entryMatchpoint Therapeutics, a biotech company working with Novartis, announced the close of a new financing round. The round raised $150 million in Series B funding. The capital will be used to advan…
- Biotech VC Forbion raises record €2.3 bn ($2.6 bn) to back 30 high-potential life-science companiesForbion announced a record fundraising of €2.3 bn ($2.6 bn) across two new funds, bringing its assets under management to about €7.5 bn ($8.4 bn). The capital will be allocated through the Forbion…